Speaker(s): 

Rowena Jimenez, MD, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Review clinical courses/pathways of HSV-encephalitis
  • Describe what is currently known about autoimmune encephalitis after HSV encephalitis

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stanley Martin, MD, Julie Gombert, RN and Bradley Lauver, PharmD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.

Session date: 
03/27/2024 - 9:00am to 10:00am EDT
Location: 
Virtual Meeting
Danville, PA 17822
United States
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation Credit

Please login or register to take this course.